Mike Brock > Kirkland & Ellis LLP > Washington DC, United States > Lawyer Profile
Kirkland & Ellis LLP Offices

1301 Pennsylvania Avenue, N.W.
Washington, D.C., 20004
DISTRICT OF COLUMBIA
United States
- Firm Profile
- Go to...
Mike Brock

Position
Robert “Mike” Brock is a nationally recognized trial lawyer with 25 years of experience handling high-stakes, bet-the-business litigation. His practice focuses on representing pharmaceuticals and life sciences companies, particularly in product liability and mass tort cases. He has tried cases in a wide range of areas and has represented clients in antitrust, malpractice, toxic tort and securities class action litigation, as well as in other types of cases. Mike is a fellow of the American College of Trial Lawyers.
Mike has represented companies in some of the most high-stakes litigation in recent history. He currently serves as lead trial lawyer for BP in the Deepwater Horizon oil spill litigation. His trial performance has been highly praised and widely reported in the press. According to the Financial Times, one legal professional said that “in a courtroom full of top-tier legal talent,” Mike was particularly impressive, delivering “one of the most methodical and skillful cross-examinations I have seen” in 25 years.
Mike has also been exceptionally successful in his representations of leading pharmaceutical companies in product liability cases. He secured jury verdicts for Merck in a Fosamax® case in New York City and for AstraZeneca in its first Seroquel® lawsuit in New Brunswick, NJ. He also served as lead trial counsel to Merck in several Vioxx® cases, securing wins in Alabama, California, Florida and New Jersey. Recently, he has served as lead trial counsel for Pfizer in its Chantix® litigation and for Boehringer Ingelheim in litigation concerning Pradaxa®.
Mike is recognized by various legal publications as a first-class trial lawyer in products liability and mass tort litigation. He has been selected as a “leading lawyer” by Chambers USA, America’s Leading Lawyers for Business every year since 2009 and the current edition describes him as “a seasoned trial lawyer who boasts impressive experience representing a range of defendants in high-stakes product liability trials.” Sources for the guide say he is “one of the elite trial lawyers in the U.S.” with a “great courtroom presence” and an ability to “take complex issues and break them down in a way that’s accessible and understandable” and is “a first-rate first-chair trial lawyer” who “is front and center” in major disputes. He was also listed in the 2015–2023 editions of Chambers Global, The World’s Leading Lawyers for Business. The Legal 500 U.S. selected Mike to the “Hall of Fame” in 2021 and as a “leading lawyer” in 2014, 2015, 2018, 2019, 2020, and 2022 for Product Liability, Mass Tort and Class Action: Pharmaceuticals and Medical Devices, and singled him out as a “renowned trial lawyer.” He is also recognized by Legal 500 for Energy: Litigation and by Benchmark Litigation as a “National Star.”
Prior to joining Kirkland, Mike was a partner at Covington & Burling LLP, where he was the chair of their product liability and mass torts practice.
Lawyer Rankings
United States > Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
(Hall of Fame)Noted for its ‘highly strategic approach’, which combines first-chair trial skills, alongside deep subject knowledge and procedural expertise, Kirkland & Ellis LLP is a popular choice among life sciences and pharma companies facing down high-stakes, bet-the-company litigation. Jennifer Levy in Washington DC and Chicago-based Donna Welch have been pivotal to the firm’s success in the area, most notably for their ‘outstanding’ work on behalf of Allergan, as one of the defendants accused in private and government-led litigation for its role in fuelling the opioid epidemic in the US. ‘Well-respected’ Washington-DC-based trial lawyer Mike Brock is also a key member of the team and has notched up numerous successes for pharma and life sciences companies, particularly in product liability and mass tort cases.
United States > Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
Noted for its trial-ready approach and ability to run large-scale teams in resource intensive MDLs, Kirkland & Ellis LLP is a popular choice among clients seeking to defend toxic tort allegations in federal and state courts throughout the country. The team has developed particular expertise defending pharmaceutical companies in relation to consolidated personal injury claims initiated by consumers of their products, as well as those sustained by former employees of production facilities and nearby residents. Washington-DC based partner Mike Brock is one of many acclaimed trial lawyers at the firm, and excels in trials involving complex scientific issues, particularly within the pharma space.
United States > Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
Centered around its Chicago, New York and Washington DC offices, in particular, Kirkland & Ellis LLP has forged a strong reputation in the space, as a result of its representation of a varied array of consumer-facing manufacturers across a myriad product liability and mass tort matters. Many of these have taken the form of large aggregate disputes. As well as the firm’s technical expertise in often highly scientific issues under dispute and its procedural prowess, it is also able to call upon the proficiency of a slew of accomplished first-chair trial lawyers, ensuring that clients are vigorously defended in jury trials, as well as providing a degree of leverage in the context of early settlements. A fellow of the American College of Trial Lawyers, Washington DC-based partner Mike Brock is a formidable practitioner in high-stakes product liability litigation, and has handled jury trials across a multitude of high-profile product liability matters, including in the automotive and pharmaceuticals industries. Drawing upon a storied career in private practice, as well as by dint of his former positions as a federal judge and high-ranking Justice Department official, Chicago-based Mark Filip has an excellent perspective of big-ticket litigation, and offers experience to defendants seeking representation at a trial stage.
United States > Dispute resolution > Product liability, mass tort and class action - defense: automotive/transport
Drawing upon a trial-ready approach should the need arise, litigation powerhouse Kirkland & Ellis LLP is a popular choice among major automotive brands in the defence of high-profile potentially reputational threatening litigation. General Motors remains a cornerstone client for the firm, with Renee Smith continuing to represent the automotive giant across a range of class actions and MDLs, including as it relates to the high-profile Takata airbag inflator recall and its alleged use of emissions defeat devices. Although he has perhaps gained most acclaim for his product liability work in the pharmaceuticals space, ‘well-respected’ Washington DC-based practitioner Mike Brock has also handled a considerable amount of work in the automotive space and is one of many experienced trial lawyers at the firm who is adept at handling a myriad bet-the-company defense work before both judges and juries. All named practitioners are based out of Chicago unless otherwise noted.
Lawyer Rankings
- Hall of Fame United States > Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Product liability, mass tort and class action - defense: automotive/transport United States > Dispute resolution
- Product liability, mass tort and class action - defense: consumer products (including tobacco) United States > Dispute resolution
- Product liability, mass tort and class action - defense: pharmaceuticals and medical devices United States > Dispute resolution
- Product liability, mass tort and class action - defense: toxic tort United States > Dispute resolution
Top Tier Firm Rankings
- Media, technology and telecoms > Advertising and marketing: litigation
- Finance > Capital markets: high-yield debt offerings
- International Trade > CFIUS
- Antitrust > Civil litigation/class actions: defense
- Government > Government relations
- Intellectual property > Copyright
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy litigation: oil and gas
- Energy > Energy transactions: electric power
- Energy > Energy transactions: oil and gas
- Environment > Environment: transactional
- Dispute resolution > General commercial disputes
- Tax > International tax
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: litigation (full coverage)
- M&A/corporate and commercial > Private equity buyouts
- Investment fund formation and management > Private equity funds (including venture capital)
- Real estate > Real estate
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Securities litigation: defense
- M&A/corporate and commercial > Shareholder activism
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Intellectual property > Trademarks: litigation
- Tax > US taxes: non-contentious
Firm Rankings
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Antitrust > Cartel
- Energy > Energy regulation: electric power
- Environment > Environment: litigation
- Media, technology and telecoms > Media and entertainment: litigation
- Antitrust > Merger control
- Media, technology and telecoms > Outsourcing
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (International Trade Commission)
- Dispute resolution > Product liability, mass tort and class action - defense: automotive/transport
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Finance > Project finance
- Real estate > Real estate investment trusts (REITs)
- Government > State attorneys general
- Finance > Structured finance: securitization
- Tax > US taxes: contentious
- Dispute resolution > E-discovery
- Dispute resolution > Financial services litigation
- Insurance > Insurance: non-contentious
- Energy > Renewable/alternative power
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Energy > Energy regulation: oil and gas
- Dispute resolution > Leading trial lawyers
- Healthcare > Life sciences
- Media, technology and telecoms > Media and entertainment: transactional
- Real estate > Construction (including construction litigation)
- International Trade > Customs, export controls and economic sanctions
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Investment fund formation and management > Mutual/registered/exchange-traded funds